Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-002502

Chief Accounting Officer gave up 99 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Peterson Katharine · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-14 Shares withheld for taxes : show line 1 in the form −99 $1.92 $190 3,907 D
Loading xslF345X06/form4.xml…